{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T21:36:56Z","timestamp":1758231416307,"version":"3.44.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jaad.2025.06.051","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T05:07:52Z","timestamp":1752642472000},"page":"1027-1034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of prognostic models using novel inflammatory markers for drug reactions with eosinophilia and systemic symptoms: An international multicenter cohort study"],"prefix":"10.1016","volume":"93","author":[{"given":"Tyng-Shiuan","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haur Yueh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riichiro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Takei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumi","family":"Hama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Tsu","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9370-3279","authenticated-orcid":false,"given":"Chia-Yu","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jaad.2025.06.051_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tox.2004.12.022","article-title":"Clinical heterogeneity of drug hypersensitivity","volume":"209","author":"Roujeau","year":"2005","journal-title":"Toxicology"},{"issue":"10106","key":"10.1016\/j.jaad.2025.06.051_bib2","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/S0140-6736(16)30378-6","article-title":"Severe cutaneous adverse reactions to drugs","volume":"390","author":"Duong","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.051_bib3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.051_bib4","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jaad.2013.08.026","article-title":"Reply to: \u201cUsing a diagnostic score when reporting the long-term sequelae of the drug reaction with eosinophilia and systemic symptoms\u201d","volume":"69","author":"Chen","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.051_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.dsi.2017.08.006","article-title":"Fever, eosinophilia, and abnormal liver function are early signs suggestive of DRESS: a comparative study between DRESS and MPE","volume":"36","author":"Hsu","year":"2018","journal-title":"Dermatol Sin"},{"issue":"12","key":"10.1016\/j.jaad.2025.06.051_bib6","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/archdermatol.2010.198","article-title":"Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases","volume":"146","author":"Chen","year":"2010","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.051_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.051_bib8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jdermsci.2012.10.002","volume":"69","author":"Ogawa","year":"2013","journal-title":"J Dermatol Sci"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.051_bib9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/bjd.12081","article-title":"Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases","volume":"168","author":"Walsh","year":"2013","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.051_bib10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1586\/14779072.2016.1154788","article-title":"Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update","volume":"14","author":"Afari","year":"2016","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.051_bib11","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1186\/s12885-019-5903-y","article-title":"Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer","volume":"19","author":"Hirahara","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jaad.2025.06.051_bib12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jss.2019.09.034","article-title":"Lymphocyte-monocyte ratio significantly predicts recurrence in papillary thyroid cancer","volume":"246","author":"Yokota","year":"2020","journal-title":"J Surg Res"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.051_bib13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12865-020-00369-6","article-title":"Prognostic role of red blood cell distribution width in patients with sepsis: a systematic review and meta-analysis","volume":"21","author":"Zhang","year":"2020","journal-title":"BMC Immunol"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.051_bib14","first-page":"348","article-title":"Red cell distribution width as a marker of activity in inflammatory bowel disease: a narrative review","volume":"33","author":"Katsaros","year":"2020","journal-title":"Ann Gastroenterol"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.051_bib15","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3390\/ijms18061243","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an interplay among drugs, viruses, and immune system","volume":"18","author":"Cho","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.051_bib16","doi-asserted-by":"crossref","first-page":"e382","DOI":"10.1111\/jdv.18578","article-title":"Novel inflammatory markers and in-hospital mortality in epidermal necrolysis-A monocentric study of 137 patients","volume":"37","author":"Bettuzzi","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.051_bib17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/jamadermatol.2021.5119","article-title":"Improvement of mortality prognostication in patients with epidermal necrolysis: the role of novel inflammatory markers and proposed revision of SCORTEN (Re-SCORTEN)","volume":"158","author":"Koh","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.051_bib18","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaad.2018.08.052","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms severity score: a useful tool for assessing disease severity and predicting fatal cytomegalovirus disease","volume":"80","author":"Mizukawa","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.051_bib19","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jaip.2021.10.042","article-title":"Serum soluble OX40 as a diagnostic and prognostic biomarker for drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms","volume":"10","author":"Mitsui","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.051_bib20","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/bjd.18942","article-title":"The interferon-gamma-induced protein 10\/CXCR3 axis is associated with human herpesvirus-6 reactivation and the development of sequelae in drug reaction with eosinophilia and systemic symptoms","volume":"183","author":"Yang","year":"2020","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2025.06.051_bib21","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1468-3083.2008.02585.x","article-title":"Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan","volume":"22","author":"Chiou","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"10.1016\/j.jaad.2025.06.051_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003839","article-title":"In vivo volume and hemoglobin dynamics of human red blood cells","volume":"10","author":"Malka","year":"2014","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.jaad.2025.06.051_bib23","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.48590","article-title":"Single-cell modeling of routine clinical blood tests reveals transient dynamics of human response to blood loss","volume":"8","author":"Chaudhury","year":"2019","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.051_bib24","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/ajh.23982","article-title":"Modulation of red blood cell population dynamics is a fundamental homeostatic response to disease","volume":"90","author":"Patel","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaad.2025.06.051_bib25","article-title":"An overall and dose-response meta-analysis of red blood cell distribution width and CVD outcomes","volume":"7","author":"Hou","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.051_bib26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pulmoe.2022.04.001","article-title":"Red cell distribution in critically ill patients with chronic obstructive pulmonary disease","volume":"30","author":"Lan","year":"2022","journal-title":"Pulmonology"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.051_bib27","article-title":"Red cell distribution width as a predictor of mortality in patients with sepsis","volume":"13","author":"Krishna","year":"2021","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.051_bib28","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/gerona\/glp163","article-title":"Red cell distribution width and mortality in older adults: a meta-analysis","volume":"65","author":"Patel","year":"2010","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jaad.2025.06.051_bib29","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8914617","article-title":"Relationship of red blood cell distribution width with cancer mortality in hospital","volume":"2018","author":"Li","year":"2018","journal-title":"Biomed Res Int"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.051_bib30","doi-asserted-by":"crossref","first-page":"628","DOI":"10.5858\/133.4.628","article-title":"Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients","volume":"133","author":"Lippi","year":"2009","journal-title":"Arch Pathol Lab Med"},{"issue":"12","key":"10.1016\/j.jaad.2025.06.051_bib31","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/archderm.143.12.1591-a","article-title":"High procalcitonin levels in patients with severe drug reactions","volume":"143","author":"Sfia","year":"2007","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.051_bib32","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.12998\/wjcc.v9.i6.1259","article-title":"New indicators in evaluation of hemolysis, elevated liver enzymes, and low platelet syndrome: a case-control study","volume":"9","author":"Kang","year":"2021","journal-title":"World J Clin Cases"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.051_bib33","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jaad.2018.10.064","article-title":"Abnormal erythrocyte morphology in drug reaction with eosinophilia and systemic symptoms","volume":"80","author":"Dorrell","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.051_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2019.01.027","article-title":"Comment on \u201cAbnormal erythrocyte morphology in drug reaction with eosinophilia and systemic symptoms\u201d","volume":"80","author":"Cho","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.051_bib35","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/MOH.0000000000000679","article-title":"Novel concepts in red blood cell clearance","volume":"28","author":"Neri","year":"2021","journal-title":"Curr Opin Hematol"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.051_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000416","article-title":"Quantitative analysis of mechanisms that govern red blood cell age structure and dynamics during anaemia","volume":"5","author":"Savill","year":"2009","journal-title":"PLoS Comput Biol"},{"issue":"9","key":"10.1016\/j.jaad.2025.06.051_bib37","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1177\/0003319719845186","article-title":"Platelet to lymphocyte ratio in cardiovascular diseases: a systematic review","volume":"70","author":"Kurtul","year":"2019","journal-title":"Angiology"},{"issue":"12","key":"10.1016\/j.jaad.2025.06.051_bib38","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.3390\/cells11121957","article-title":"Platelets at the crossroads of pro-inflammatory and resolution pathways during inflammation","volume":"11","author":"Ludwig","year":"2022","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.jaad.2025.06.051_bib39","doi-asserted-by":"crossref","first-page":"8071","DOI":"10.4049\/jimmunol.0804002","article-title":"Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome","volume":"182","author":"Takahashi","year":"2009","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.jaad.2025.06.051_bib40","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri3070","article-title":"Monocyte recruitment during infection and inflammation","volume":"11","author":"Shi","year":"2011","journal-title":"Nat Rev Immunol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225023801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225023801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T12:20:16Z","timestamp":1758198016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225023801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0190962225023801"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.06.051","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of prognostic models using novel inflammatory markers for drug reactions with eosinophilia and systemic symptoms: An international multicenter cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.06.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}